Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, 13009, France
NCT Number: NCT03685799
Influence of histological concordance on the risk of recurrence:
the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Marseille, Bouches-du Rhône, 13009, France
Influence of histological concordance on the risk of recurrence:
the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Pathological revision
Time frame: 1 day
the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.
Time frame: 1 day
Identification of histological factors of recurrence.
Institut Paoli-Calmettes
Other
Acronym: PatheBarett
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06030180
Adenocarcinoma Of Esophagus, Barrett Esophagus
Heber Springs, Arkansas, United States
View Trial DetailsNCT06381583
Adenocarcinoma Of Esophagus, Barrett Adenocarcinoma
Duarte, California, United States
View Trial DetailsNCT04293458
Adenocarcinoma Of Esophagus, Barrett Esophagus
Orange, California, United States
View Trial DetailsNCT05530343
Adenocarcinoma Of Esophagus, Barrett Esophagus
Gilbert, Arizona, United States
View Trial Details